Ribocil
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Ribocil is chemical compound which is found to be a potent inhibitor of the FMN riboswitch, meaning it could serve as a promising lead compound for developing a new antibiotic class. The compound was discovered by Merck & Co. through a phenotypic screen of the Gram-positive bacteria Staphylococcus aureus. The binding mode of this small molecule to its binding site has been confirmed through the use of X-Ray crystallography.
Ribocil is chemical compound which is found to be a potent inhibitor of the FMN riboswitch, meaning it could serve as a promising lead compound for developing a new antibiotic class. The compound was discovered by Merck & Co. through a phenotypic screen of the Gram-positive bacteria Staphylococcus aureus. The binding mode of this small molecule to its binding site has been confirmed through the use of X-Ray crystallography.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1337157321 under CC BY-SA 4.0; modifications have been made.